Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Speaker announcement
: First Lady Jill Biden to Speak at Fierce JPM Week on January 14th
Merck KGaA
Pharma
Merck and BioNTech's I-O bispecific buys—Fierce Pharma Asia
Merck and BioNTech bought Chinese biotechs to gain bispecifics. AZ and Daiichi refiled their TROP2 antibody-drug conjugate with the FDA. And more.
Angus Liu
Nov 15, 2024 8:20am
MilliporeSigma's production push rolls with $76M ADC investment
Oct 29, 2024 10:33am
Merck-Curon, Legend, Amgen—Fierce Pharma Asia
Aug 16, 2024 8:59am
Merck KGaA, analysts share optimism about potential CDMO rebound
Aug 7, 2024 3:13pm
MilliporeSigma plugs €62M into new quality control building
Jun 14, 2024 10:00am
Novo, Novartis, BMS among pharmas celebrating LGBTQ+ Pride month
Jun 12, 2024 11:40am
